Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - tanaji talele
Novel “DNA trapping” and “Non-trapping” PARP Inhibitors
Candidate PARPi compounds with strong anti-cancer capabilities (i.e. “DNA trappers”) and PARPi candidates with low cellular toxicity for treatment of stroke, diabetes, myocardial infarction, neurodegenerative diseases and other diseases with PARP overactivation (i.e. “non-trappers”). Technology Overview: Inhibition of Poly(ADP?ribose)...
Research Tools & Reagents
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by